SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950137-08-006285
Filing Date
2008-04-29
Accepted
2008-04-29 16:25:39
Documents
8
Period of Report
2008-06-12
Effectiveness Date
2008-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT c26175ddef14a.htm DEF 14A 613726
3 GRAPHIC c26175dc2617501.gif GRAPHIC 6890
4 GRAPHIC c26175dc2617506.gif GRAPHIC 1360
5 GRAPHIC c26175dc2617500.gif GRAPHIC 3036
6 GRAPHIC c26175dc2617505.gif GRAPHIC 1300
7 GRAPHIC c26175dc2617503.gif GRAPHIC 5139
8 GRAPHIC c26175dc2617507.gif GRAPHIC 2414
9 GRAPHIC c26175dc2617502.gif GRAPHIC 5184
  Complete submission text file 0000950137-08-006285.txt   651254
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 08785855
SIC: 2836 Biological Products, (No Diagnostic Substances)